Package 25021-118-10

Brand: cefuroxime sodium

Generic: cefuroxime sodium
NDC Package

Package Facts

Identity

Package NDC 25021-118-10
Digits Only 2502111810
Product NDC 25021-118
Description

25 VIAL in 1 CARTON (25021-118-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

Marketing

Marketing Status
Marketed Since 2016-09-01
Brand cefuroxime sodium
Generic cefuroxime sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "244117cb-7dfb-44fd-a670-323aae6b51f7", "openfda": {"unii": ["R8A7M9MY61"], "rxcui": ["1665444", "1665449"], "spl_set_id": ["0a145288-733a-4966-b7ae-dc96eb103d8c"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (25021-118-10)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL", "package_ndc": "25021-118-10", "marketing_start_date": "20160901"}], "brand_name": "Cefuroxime sodium", "product_id": "25021-118_244117cb-7dfb-44fd-a670-323aae6b51f7", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "25021-118", "generic_name": "Cefuroxime sodium", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cefuroxime sodium", "active_ingredients": [{"name": "CEFUROXIME SODIUM", "strength": "750 mg/1"}], "application_number": "ANDA064125", "marketing_category": "ANDA", "marketing_start_date": "20160901", "listing_expiration_date": "20261231"}